AXSM - Axsome Therapeutics to Participate in Upcoming Investor Conferences | Benzinga
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Axsome will participate in two upcoming investor conferences.
The conference details are as follows:
- William Blair 44th Annual Growth Stock Conference, on Wednesday, June 5, at 2 p.m. Central Time. Herriot Tabuteau, MD, Axsome's Chief Executive Officer, will present a corporate overview at the Loews Chicago Hotel, in Chicago.
- Goldman Sachs 45th Annual Global Healthcare Conference, on Wednesday, June 12. Axsome leadership will participate in investor meetings at the Loews Miami Beach, in Miami Beach, Florida.
A live webcast and archive of the William Blair presentation can be viewed on the "Webcasts & Presentations" page of the "Investors" section of the Company's website at www.axsome.com.
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. For more information, please visit the Company's website at axsome.com. The Company may occasionally disseminate material, nonpublic information on the company website.
Forward Looking Statements
Certain matters discussed in ...